Dental market gains ground
Increased confidence and greater deal activity, say Christie & Co.
Specialist business property adviser Christie & Co has launched its Dental Market Review 2025 report, which offers a panoramic view of the UK dental business sector, spotlighting sector ownership structures, market dynamics, pricing patterns and the appetite of banks to lend within the sector.
Market overview
The report begins by updating the ownership structure of the UK dental market, comprising 12,223 of which 2,203 are owned by corporates and larger groups, 2,065 by mid-sized and smaller groups and 7,955 by independent operators.
Of the corporates, mydentist leads the way with 511 practices, followed by BUPA Dental with 380 and PortmanDentex with 376 practices.
Last year was a pivotal chapter for the UK dental market, marking a transition toward a more sustainable, quality-driven and independently led landscape, with more than 80 per cent of Christie & Co deals agreed with independent owners.
However, in the first half of 2025, Christie & Co saw the re-entry of corporate and group buyers into the market, buoyed by stabilising interest rates and a renewed focus on quality over scale. Many larger groups spent much of 2023 and 2024 refining their portfolios and operating models and are now expected to return to acquisitive strategies, but in a more targeted, strategic fashion.
Key trends
In 2024, 74% of Christie & Co’s completed deals were to independent operators (one to two sites), 11 per cent to mid-sized and smaller groups (three to 29 sites), and 15 per cent to corporates and larger groups (more than 30 sites).
Across all buyer types, there is a sector-wide movement away from purely NHS dentistry and towards mixed and private practices. Between 2023 and the first half of 2025, corporate buyers increasingly targeted private dental practices, reflecting a strategic shift toward higher-margin, consumer-driven models amid NHS funding challenges.
Small and medium-sized groups also leaned more toward private and mixed (private) acquisitions. While independent and first-time buyers initially preferred NHS practices, by this year they had begun pivoting toward private models. This shift reflects changing buyer expectations, increased access to funding, and a response to the perceived stability and profitability of private dentistry amid NHS uncertainty.
Deferred consideration has emerged as a strategic mechanism in dental practice transactions, especially in corporate acquisitions. Small groups and independents, while less frequent users of deferred structures, still show notable engagement, especially in recent periods. This suggests a growing sophistication and a willingness to adopt corporate-style deal mechanics to remain competitive. Over 2024 and the first half of this year, 16% of deals had deferred consideration – including 36% of corporate and large group deals, and 12% of small group and independent deals.
Pricing
The UK dental market has continued its recalibration following a 9.4% price decline in 2024, with early 2025 data indicating a 2.9% increase in prices, signalling stabilisation and selective growth. Buyers, especially consolidators and private equity groups, are prioritising quality, seeking practices with stable teams and growth potential. As corporate buyers re-enter the market, competition is expected to drive up average multiples and deferred pricing.
Valuation multiples have largely steadied, with NHS and private practices maintaining strong buyer interest, while mixed practices saw only minor pricing adjustments. Associate-led practices are expected to retain stable EBITDA multiples, with potential for growth driven by increasing buyer appetite and a robust opportunity pipeline. Private and private-led practices are well-positioned to benefit from strong buyer demand, particularly in elective and cosmetic dentistry. London and the South East remain high-value regions, with Associate-led practices in London achieving EBITDA multiples up to 7.7x.
In 2024, 68% of all accepted offers were at or above the asking price, which included 49 per cent over the asking price. Some 48% of offers not accepted were also at and above the asking price, which is most likely due to competitive interest and multiple offers being received on individual market opportunities.
Sentiment in the sector
- In June this year, Christie & Co reached out to over 38,000 dental professionals from across the UK to get their views on a range of topics. Key findings include:
- Overall, more feel positive or neutral about the sector than feel negative, where 73% of Hygienist/Therapists feel that is the case (reflecting the highest proportion), while 54% of others in the sector reflect the lowest proportion
- 48 to 77% feel demand for NHS dentistry has increased, compared with 50 to 65% in 2024, suggesting that overall patient demand for NHS dentistry continues to rise year-on-year
- 40% of respondents feel that demand has increased for high-end elective treatments. In 2024, 40% of respondents also felt the same. This would suggest that there is potentially an ongoing and continued easing in patients choosing to defer such treatments
- It was felt that the greatest area of growth is likely to come through general dentistry (28% to 30%), with specialist services (24 to 26%) just marginally behind
- The majority (86%) of respondents feel that digital dentistry is at the forefront of future growth. Some 90% of those respondents in the private operational segment feel this is the case, 86% of those in the mixed segment, and 63% of those in the NHS-focused segment
- Almost half of the respondents (49%) feel that they are most likely to invest in new technology and equipment in the coming 12 to 24 months. 29% of respondents say that recruiting additional staff is their next most likely investment
- Overall, the largest potential influencers in decision making are operational costs (29%), cash flow (24%) and recruitment and retention (24%). Whilst in the main, and across the mixed and private operational segments, those influencers are broadly in line, there is a clear differential from those who work or are involved in the NHS-led segment, where the largest influencer at 34% is felt likely to be recruitment and retention.
Paul Graham, Managing Director – Medical at Christie & Co, said: “Independent operators remain a powerful driving force, yet we are also witnessing the return of corporate and group buyers who are now acting with greater discipline and selectivity.
“Alongside this, the emergence of new investors and fresh capital entering the sector is driving consolidation, but in a more disciplined, strategic way than in previous cycles. This balance is creating a competitive environment, and for owners considering their next step, it represents a moment of real opportunity to achieve strong outcomes and maximise long-term value. Following the market correction a couple of years ago, this renewed stability has been long overdue – it’s encouraging to see it gathering pace now.”
To read the full Dental Market Review 2025 report, which also includes a look at the finance landscape from Christie Finance and the insurance landscape from Christie Insurance, the impact of the NHS 10-Year Plan on the market, and an insightful Q&A with Raj Rattan MBE, visit www.christie.com to find out more.
Comments are closed here.